DC
ARCT icon

Davenport & Co’s Arcturus Therapeutics ARCT Stock Holding History

Davenport & Co’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,900
Closed -$369K – 1157
2024
Q3 		$369K Buy
15,900
+4,400
+38% +$94.1K ﹤0.01% 912
2024
Q2 		$280K Sell
11,500
-5,100
-31% -$155K ﹤0.01% 974
2024
Q1 		$561K Buy
16,600
+5,100
+44% +$181K ﹤0.01% 771
2023
Q4 		$363K Sell
11,500
-2,200
-16% -$52.3K ﹤0.01% 856
2023
Q3 		$350K Sell
13,700
-27,300
-67% -$841K ﹤0.01% 829
2023
Q2 		$1.18M Buy
41,000
+14,100
+52% +$384K 0.01% 515
2023
Q1 		$645K Buy
+26,900
New +$483K 0.01% 657

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return